FindTrial
Sign In

Clinical Profile Of kidney disease

Clinical Profile And Outcome Of Patients With C3 Dominant Glomerulonephritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053254
Enrollment
150
Registered
2023-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N055- Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis

Interventions

Control Intervention1: NIL: NIL

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All biopsy proven cases of C3 Dominant Glomerulonephritis from 1 January 2013 to 31 December 2023

Exclusion criteria

Exclusion criteria: Clinically suspected cases of C3 Dominant Glomerulonephritis who have not undergone a kidney biopsy.

Design outcomes

Primary

MeasureTime frame
Complications, Resolution and Mortality of patients with C3 dominant glomerulonephritisTimepoint: 12 MONTHS—

Secondary

MeasureTime frame
Percentage of Post infectious glomerulonephritis patients who progressed to C3 glomerulopathy.Timepoint: 12 MONTHS—

Countries

India

Contacts

Public ContactVishrut Khullar

Department of Nephrology Kasturba Medical College Manipal Udupi

ravindra.prabhu@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026